Studienserver - Medizinische Hochschule Hannover

Studies: Desmoidstudie

ID Trial

CSTI571BDE70

EudraCT number

2007-000624-40

Clinicaltrials.gov identifier

NCT01137916

Description

Phase II study to evaluate glivec (imatinib mesylate) to induce progression arrest in aggressive fibromatosis / desmoid tumors not amendable to surgical resection with R0 intent or accompanied by unacceptable function loss

Status

active